MetaCap

4D Molecular Therapeutics (FDMT) News

NASDAQ: FDMTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

10.23-0.49 (-4.57%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

FDMT news summary

We found 7 recent headlines mentioning 4D Molecular Therapeutics (FDMT): 0 in the past week and 6 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, FDMT is down 4.57% at $10.23. The most recent story, "4DMT Announces New Employment Inducement Grants", was published by GlobeNewswire on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest 4D Molecular Therapeutics headlines

Stocks mentioned alongside FDMT

Compare FDMT